Ann: MVP Roadshow Presentation, page-12

Regarding the continuous flow technology…

John Sharman and Others visited an international drug show in Frankfurt around January
/February this year. There they pitched the continuous flow technology to some of the worlds largest drug Manufacturers. But what have been the result so far? Comments to Phillips Capital in their investment report said that MDI would close a deal before the end of 2020. Of recent months… No news.

The Latest roadshow says that they are having engineering problems in stage four of production. What are those engineering problems? How serious are they? When do they expect to overcome them?

These would be good questions to ask at the annual board meeting this year.

There's also the issue of likely competitors. Some American drug Manufacturers have been given US government assistance to develop continuous flow technology covering drugs including those that MDI is targeting. How mature is our technology compare to theirs? Is there a risk that we will be too slow To develop our product?

Lots of questions need to be answered for investors to have real confidence.